Cite
Uncovering molecular targets for regenerative therapy in degenerative disc disease: do small leucine-rich proteoglycans hold the key?
MLA
Rajasekaran, Shanmuganathan, et al. “Uncovering Molecular Targets for Regenerative Therapy in Degenerative Disc Disease: Do Small Leucine-Rich Proteoglycans Hold the Key?” Spine Journal, vol. 21, no. 1, Jan. 2021, pp. 5–19. EBSCOhost, https://doi.org/10.1016/j.spinee.2020.04.011.
APA
Rajasekaran, S., Soundararajan, D. C. R., Tangavel, C., Nayagam, S. M., K S, S. V., R, S., Matchado, M. S., Muthurajan, R., Shetty, A. P., Kanna, R. M., & K, D. (2021). Uncovering molecular targets for regenerative therapy in degenerative disc disease: do small leucine-rich proteoglycans hold the key? Spine Journal, 21(1), 5–19. https://doi.org/10.1016/j.spinee.2020.04.011
Chicago
Rajasekaran, Shanmuganathan, Dilip Chand Raja Soundararajan, Chitraa Tangavel, Sharon Miracle Nayagam, Sri Vijayanand K S, Sunmathi R, Monica Steffi Matchado, et al. 2021. “Uncovering Molecular Targets for Regenerative Therapy in Degenerative Disc Disease: Do Small Leucine-Rich Proteoglycans Hold the Key?” Spine Journal 21 (1): 5–19. doi:10.1016/j.spinee.2020.04.011.